Get my own profile
Public access
View all34 articles
5 articles
available
not available
Based on funding mandates
Co-authors
- Laurel Mydock-McGraneFimbrion TherapeuticsVerified email at fimbrion.com
- Scott WildmanUniversity of Wisconsin-MadisonVerified email at wisc.edu
- Vishnu C. Damalanka, Ph.DResearch InstructorVerified email at wustl.edu
- Jeremy GreenGreen Chemistry Consulting LLCVerified email at hms.harvard.edu
- Vasilios Kalas, MD, PhDMcGaw Medical Center of Northwestern UniversityVerified email at northwestern.edu
- Amarendar MaddiralaWashington University in St.Louis School of MedicineVerified email at wustl.edu
- Dorin ToaderDirector at Mersana TherapeuticsVerified email at mersana.com
- Thomas J. HannanWashington UniversityVerified email at wustl.edu
- Jeffrey P Henderson, MD, PhD, FIDSADivision of Infectious Diseases, Department of Medicine, Washington UniversityVerified email at wustl.edu
- Partha KarmakarAbzena, Bristol, PA, USAVerified email at wustl.edu
- Michael E. HibbingFimbrion Therapeutics. Inc.Verified email at Fimbrion.com
- Daved H. FremontDepartment of Pathology and Immunology, Washington UniversityVerified email at wustl.edu
- L. David SibleyWashington University in St. LouisVerified email at wustl.edu
- Makedonka MitrevaProfessor of Medicine, Washington University School of MedicineVerified email at wustl.edu
- Cassie JarvisSenior Scientist, MerckVerified email at merck.com
- Ursula GermannOnKognos Scientific Consulting & ServicesVerified email at onkognos.com
- Marc JacobsVertex PharmaceuticalsVerified email at vrtx.com
- Robert GalemmoVerge GenomicsVerified email at galemmoconsulting.com
- Bin YangExecutive Director, Medicinal Chemistry, Kymera TherapeuticsVerified email at kymeratx.com
- Stephanie SpringerFDAVerified email at fda.hhs.gov
Follow
James W. Janetka
Professor, Washington University School of Medicine
Verified email at wustl.edu - Homepage